Cho, MN
Andrew Pomjin Cho, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20140263264 | Heated Garment and Battery Holster - A heated garment system in one embodiment includes a jacket, a wiring circuit embedded within the jacket and configured to generate heat, a battery assembly configured to removably couple with the wiring circuit, the battery assembly including a power button for selectively applying power to the wiring circuit, and a battery holder configured to removably receive the battery assembly. | 09-18-2014 |
Euhnee Cho, Maplewood, MN US
Patent application number | Description | Published |
---|---|---|
20140243969 | PROSTHETIC HEART VALVE WITH EXPANDABLE MICROSPHERES - A prosthetic heart valve includes a valve assembly mounted to an expandable stent. The prosthetic heart valve includes a cuff coupled to the stent. The cuff includes a pocket formed between an outer side and an inner side of the cuff. The pocket includes a plurality of biocompatible and irreversibly expandable microspheres. After implantation of the prosthetic heart valve into a patient, any gaps existing between the cuff and the native heart valve are exposed to bodily fluid, such as blood. The blood enters the pocket of the cuff through pores in the outer side of the cuff. The blood interacts with the microspheres, causing irreversible expansion of the microspheres. The microspheres expand to fill any gaps between the prosthetic heart valve and the native heart tissue, sealing the gaps and preventing leakage through the gaps. | 08-28-2014 |
20140257275 | THERMOCHROMIC POLYVINYL ALCOHOL BASED HYDROGEL ARTERY - A method of creating a thermochromic artificial blood vessel includes physically cross-linking a polyvinyl alcohol solution in a mold shaped to mimic a blood vessel to create an artificial blood vessel. The artificial tissue is then chemically cross-linked with a solution including a chemical cross-linking reagent. A coagulation solution is then applied to the artificial blood vessel to both inhibit the chemical cross-linking and promote physical cross-linking of the artificial blood vessel. The artificial blood vessel can be used to test an ablation catheter. The vessel, when heated by the ablation catheter, changes color and/or transparency at locations where the temperature of artificial blood vessel increases. | 09-11-2014 |
Yongduk Cho, Maple Grove, MN US
Patent application number | Description | Published |
---|---|---|
20100217135 | METHOD AND SYSTEM FOR INTERPRETING HEMODYNAMIC DATA INCORPORATING PATIENT POSTURE INFORMATION - Systems and methods for improving hemodynamic data interpretation by accounting for the effects of patient posture is disclosed. In certain embodiments, a posture signal is acquired and used to categorize hemodynamic data according to posture to facilitate distinguishing posture-related changes in acquired hemodynamic data from those due to pathophysiologic changes. Posture information may be used to normalize data acquired in various postures to facilitate interpretation of such data. Baseline measurements of hemodynamic data acquired in various postures may also be used to subsequently detect changes in patient posture without the need for an implanted posture sensor. | 08-26-2010 |
Yong K. Cho, Ham Lake, MN US
Patent application number | Description | Published |
---|---|---|
20130110190 | METHOD TO ASSESS HEMODYNAMIC PERFORMANCE DURING CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION USING ADMITTANCE WAVEFORMS AND DERIVATIVES | 05-02-2013 |
Yong K. Cho, Mapple Grove, MN US
Patent application number | Description | Published |
---|---|---|
20100113888 | HEART FAILURE DECOMPENSATION DETERMINATION - Heart failure decompensation is detected by sensing at least one physiological signal. Values of at least two different heart failure variables are derived using one or more physiological signals and a threshold for the first heart failure variable is adjusted in response to the value of the second heart failure variable. The value of the first heart failure variable is compared to first threshold for detecting a heart failure condition. | 05-06-2010 |
Yong K. Cho, Excelsior, MN US
Patent application number | Description | Published |
---|---|---|
20150045848 | MEDICAL DEVICE TO PROVIDE BREATHING THERAPY - Medical devices and methods for providing breathing therapy (e.g., for treating heart failure, hypertension, etc.) may determine at least the inspiration phase of one or more breathing cycles based on the monitored physiological parameters and control delivery of a plurality of breathing therapy sessions (e.g., each of the breathing therapy sessions may be provided during a defined time period). Further, each of the plurality of breathing therapy sessions may include delivering stimulation after the start of the inspiration phase of each of a plurality of breathing cycles to prolong diaphragm contraction during the breathing cycle. | 02-12-2015 |
Yong Kyun Cho, Maple Grove, MN US
Patent application number | Description | Published |
---|---|---|
20090171220 | METHODS FOR DETECTING AND MONITORING SLEEP DISORDERED BREATHING USING AN IMPLANTABLE MEDICAL DEVICE - A method of identifying sleep disordered breathing (SDB) in a patient includes monitoring a hemodynamic pressure, deriving high, middle, and low values representative of the distribution of the hemodynamic pressure over a storage interval, measuring a ratio of a lower range to a full range of the hemodynamic pressure based on the derived high, middle, and low values, and using the ratio to determine whether the patient has experienced an SDB episode. Certain embodiments of the invention compare the ratio to a threshold value to identify the occurrence of an SDB episode, while other embodiments of the invention identify the occurrence of an SDB episode by monitoring for a simultaneous increase in both the ratio and the full range of the hemodynamic pressure. In certain other embodiments of the invention, activity level and/or duration criteria may be employed to confirm the occurrence of an SDB episode detected using the ratio. | 07-02-2009 |
20090234405 | SYSTEM AND METHOD FOR CARDIAC LEAD SWITCHING - An implantable medical device (IMD) can include an implantable pulse generator (IPG), such as a cardiac pacemaker or an implantable cardioverter-defibrillator (ICD). Various portions of the IMD, such as a device body, a lead body, or a lead tip, can be provided to reduce or dissipate a current and heat induced by various external environmental factors. According to various embodiments, features can be incorporated into the lead body, the lead tip, or the IMD body to reduce the creation of an induced current, or dissipate the induced current and heat created due to an induced current in the lead. | 09-17-2009 |
20090270934 | Pressure and Impedance Based Discrimination of Hemodynamic Stability - An implantable cardioverter defibrillator evaluates the hemodynamic stability of an arrhythmia to determine whether or not to defibrillate. The device obtains cardiac pressure and cardiac impedance data and evaluates a phase relationship between these parameters. Hemodynamically stable rhythms will result in an out of phase relationship. | 10-29-2009 |
20100113895 | System and method for improving data management between implantable medical devices and external devices - Systems, methods and devices are provided for improving data management between implantable medical devices (IMDs) and external devices for the detection of volume overload and volume depletion conditions. Data acquired by the IMD is periodically communicated to the external device where a volume overload monitoring algorithm is operated to detect whether a volume overload condition is present in the patient by monitoring the acquired data at the external device at a first lower, non-real-time frequency rate. Upon detection of a volume overload condition, the external device issues an instruction to the IMD causing the IMD to initiate a volume depletion condition monitoring algorithm for detecting in real time whether a volume depletion condition is present in the patient. | 05-06-2010 |
20100198311 | SYSTEM AND METHOD FOR CARDIAC LEAD SWITCHING - An implantable medical device (IMD) can include an implantable pulse generator (IPG), such as a cardiac pacemaker or an implantable cardioverter-defibrillator (ICD). Various portions of the IMD, such as a device body, a lead body, or a lead tip, can be provided to reduce or dissipate a current and heat induced by various external environmental factors. According to various embodiments, features can be incorporated into the lead body, the lead tip, or the IMD body to reduce the creation of an induced current, or dissipate the induced current and heat created due to an induced current in the lead. | 08-05-2010 |
20120108984 | INTEGRATED PATIENT CARE - A therapy regimen, e.g., a contingent medication prescription, may be created and automatically distributed to a patient via an integrated patient care system. A clinician may create therapy instructions by at least associating patient conditions with one or more therapy regimens, e.g., medication prescriptions. In some examples, the integrated patient care system may present historical condition data to the clinician to aid the clinician with creating and/or updating the therapy instructions specific to the patient. A therapy module of the integrated patient care system may use the therapy instructions to automatically select a therapy regimen from the therapy instructions based on a patient condition detected based on a sensed physiological parameter. The physiological parameter of the patient may be sensed by an implanted or external sensor. In some examples, the therapy regimen can be presented to the patient according to a predetermined schedule or in response to the detected condition. | 05-03-2012 |
20120283580 | VERIFICATION OF PRESSURE METRICS - An example system may include at least one pressure sensor configured to measure a cardiovascular pressure signal and another medical device configured to measure an electrical depolarization signal of the heart. The system determines a plurality of cardiovascular pressure metrics based on the measured cardiovascular pressure signal, including at least one cardiovascular pressure metric indicative of a timing of at least one cardiac pulse. The system also determines a metric indicative of a timing of at least one heart depolarization within the measured electrical depolarization signal. The system compares the timing of the at least one cardiac pulse to the timing of the at least one depolarization, and determines whether to discard the plurality of cardiovascular pressure metrics based on whether the timings substantially agree. | 11-08-2012 |
20120290032 | TECHNIQUES FOR MODIFYING BREATHING RATE USING CARDIAC PACING - A method includes controlling a cardiac pacing rate of an implantable medical device (IMD) to control a heart rate of a patient and determining that the patient is in a resting state. The method further includes modifying the pacing rate of the IMD for N cardiac cycles in response to determining that the patient is in the resting state. N is an integer greater than 1. Modifying the pacing rate includes incrementally increasing the pacing rate for a first portion of the N cardiac cycles, and incrementally decreasing the pacing rate for a second portion of the N cardiac cycles. | 11-15-2012 |
20120290033 | TECHNIQUES FOR MODIFYING BREATHING RATE USING CARDIAC PACING - A method includes controlling a cardiac pacing rate of an implantable medical device to control a heart rate of a patient and detecting inhalation and exhalation of the patient. The method further includes determining that the patient is in a resting state, and, in response to determining that the patient is in the resting state, incrementally increasing the pacing rate while exhalation of the patient is detected and incrementally decreasing the pacing rate while inhalation of the patient is detected. | 11-15-2012 |
Yong Kyun Cho, Excelsior, MN US
Patent application number | Description | Published |
---|---|---|
20150202436 | CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION BASED ON INTRACARDIAC IMPEDANCE - Methods and/or devices used in delivering cardiac resynchronization therapy based on a plurality of device parameters (e.g., A-V delay, V-V delay, etc.) are optimized by setting a device parameter based on selection data. The selection data may be acquired by acquiring temporal fiducial points (e.g., heart sounds) associated with at least a part of a systolic portion of at least one cardiac cycle and/or temporal fiducial points associated with at least a part of a diastolic portion of the at least one cardiac cycle for each of a plurality of electrode vector configurations, and extracting measurements from the intracardiac impedance signal acquired for each of a plurality of electrode vector configurations based on the temporal fiducial points. The acquired selection data may be scored and used to optimize the device parameter. | 07-23-2015 |
20150202443 | CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION BASED ON INTRACARDIAC IMPEDANCE AND HEART SOUNDS - Methods and/or devices used in delivering cardiac resynchronization therapy based on a plurality of device parameters (e.g., A-V delay, V-V delay, etc.) are optimized by setting a device parameter based on selection data. The selection data may be acquired by acquiring temporal fiducial points (e.g., heart sounds) associated with at least a part of a systolic portion of at least one cardiac cycle and/or temporal fiducial points associated with at least a part of a diastolic portion of the at least one cardiac cycle for each of a plurality of electrode vector configurations, and extracting measurements from the intracardiac impedance signal acquired for each of a plurality of electrode vector configurations based on the temporal fiducial points. The acquired selection data may be scored and used to optimize the device parameter. | 07-23-2015 |
Yong Yeon Cho, Rochester, MN US
Patent application number | Description | Published |
---|---|---|
20110269810 | SELECTIVE INHIBITORS OF C-JUN N-TERMINAL KINASE - Compositions and methods for treating, preventing, or ameliorating one or more symptoms, disorders, or conditions associated with particular c-Jun N-terminal kinase(s) (JNKs) activity are provided. Compositions contain small molecules such as pyrazoloanthrones. | 11-03-2011 |
Yong-Yo K.y. Cho, Maple Grove, MN US
Patent application number | Description | Published |
---|---|---|
20090270933 | Pressure and Impedance Based Discrimination of Hemodynamic Stability - An implantable cardioverter defibrillator evaluates the hemodynamic stability of an arrhythmia to determine whether or not to defibrillate. The device obtains cardiac pressure and cardiac impedance data and evaluates a phase relationship between these parameters. Hemodynamically stable rhythms will result in an out of phase relationship. | 10-29-2009 |
Young-Yeon Cho, Minneapolis, MN US
Patent application number | Description | Published |
---|---|---|
20140303244 | METHODS OF TREATING CANCER WITH HERBACETIN - The invention provides methods, uses and compounds for treating cancers. | 10-09-2014 |